Pharma News Daily | Pharma Acquisition News | Clinical Trial News

Pharma News Daily brings you pharma acquisition news, clinical trial news, pharma regulatory news, medical device news and other pharma industry news.
Pharma Industry News Check below the latest pharma industry news, pharma acquisition news, drug launch news, pharma merger news and pharma company updates from Pharma News Daily.

Novartis acquires optogenetics gene therapy company Vedere Bio

Novartis acquires optogenetics gene therapy company Vedere Bio

Novartis acquisition of Vedere Bio : US-based stealth-stage company Vedere Bio has been acquired by…

Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt

Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt

Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government…

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical…

Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt

Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt

Precision Nanosystems (PNI) has received a funding boost of up to CAD 18.2 million from…

Gilead Sciences wraps up $21bn acquisition of Immunomedics

Gilead Sciences wraps up $21bn acquisition of Immunomedics

Gilead Sciences has wrapped up its previously announced $21 billion acquisition of New Jersey-based biopharma…

Endo International to acquire BioSpecifics Technologies for $658m

Endo International to acquire BioSpecifics Technologies for $658m

Endo International has agreed to acquire BioSpecifics Technologies, a New York-based commercial-stage biopharma company, for…

Lilly to acquire SARM1 inhibitor developer Disarm Therapeutics

Lilly to acquire SARM1 inhibitor developer Disarm Therapeutics

Lilly acquisition of Disarm Therapeutics : Eli Lilly and Company (Lilly) has agreed to acquire…

Pharma Regulatory News

Check below the latest pharma regulatory news, pharma regulatory affairs, FDA drug approval news, EMA drug approval news, FDA drug submissions, EMA drug submissions from Pharma News Daily.
Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug Veklury (remdesivir) for Covid-19 treatment in patients requiring hospitalization. This makes remdesivir the first approved…

Regeneron bags Inmazeb FDA approval for treatment of Ebola

Regeneron bags Inmazeb FDA approval for treatment of Ebola

Inmazeb FDA approval : Regeneron Pharmaceuticals has secured approval from the US Food and Drug…

AstraZeneca gets FDA breakthrough status for Farxiga in CKD

AstraZeneca gets FDA breakthrough status for Farxiga in CKD

AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food…

FDA approves BMS’ Opdivo, Yervoy combo for malignant pleural mesothelioma

FDA approves BMS’ Opdivo, Yervoy combo for malignant pleural mesothelioma

Bristol Myers Squibb (BMS) has secured approval for Opdivo (nivolumab) and Yervoy (ipilimumab) combination from…

Clinical Trial News

Check below the latest clinical trial news, latest clinical trial updates, clinical trial enrollment, clinical trial results, clinical trial data, cancer clinical trials and others from Pharma News Daily.

VelosBio begins phase 2 trial of VLS-101 in solid tumors

VelosBio begins phase 2 trial of VLS-101 in solid tumors

VelosBio, a San Diego-based biopharma company, said that it has dosed the first patient in…

Check below the latest clinical trial news, latest clinical trial updates, clinical trial enrollment, clinical trial results, clinical trial data, cancer clinical trials and others from Pharma News Daily.

AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials

AstraZeneca to advance AZD7442 into phase 3 Covid-19 trials

AstraZeneca said that AZD7442, which is being developed for the prevention and treatment of Covid-19,…

Check below the latest clinical trial news, latest clinical trial updates, clinical trial enrollment, clinical trial results, clinical trial data, cancer clinical trials and others from Pharma News Daily.

IBRANCE fails to meet primary endpoint in early breast cancer trial

IBRANCE fails to meet primary endpoint in early breast cancer trial

Pfizer said that the phase 3 PENELOPE-B clinical trial of IBRANCE (palbociclib) in early breast…

AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, Brazil, Japan, and South Africa confirmed that it was safe to continue them. The US…

Thank you for visiting Pharmanewsdaily.com for pharma news daily, pharma acquisition news, clinical trial news, pharma regulatory news, medical device news and all other pharma industry news.